Results

1–10 of 14 results for Jennifer I. Lim

Vision Outcomes From the DAVIO 2 Trial: A Phase 2 Trial of EYP-1901 vs Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2025
Detection of Early Diabetic Retinopathy Using OCTA Bloodflow Analysis
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2023
Expert Panel: AI
Mark S. Humayun, MD, PhD
Devinder S Chauhan, MD FRCOphth FRANZCO
Ursula M. Schmidt-Erfurth, MD
Jennifer I. Lim, MD, FARVO, FASRS
Royce WS Chen, MD
Annual Meeting Talks
2024
Progressive Quantitative Outer Retinal Optical Coherence Tomography Abnormalities in Early Diabetic Retinopathy Compared with Controls
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2022
Artificial Intelligence Using Differential Artery-Vein Classification in OCTA Improves Detection and Staging of Sickle Cell Retinopathy
Jennifer I. Lim, MD, FARVO, FASRS
On Demand Cases, Courses, and Papers
2021
Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2022
Artificial Intelligence Screening for Diabetic Retinopathy: Subgroup Comparison of the EyeArt System with Ophthalmologists' Dilated Exams
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2020
Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2021
Wellness for the Retina Physician: Building Resilience, Improving Ergonomics, Practicing Mindfulness, and Avoiding Burnout
Janice C. Law, MD
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2019
Artificial Intelligence Screening for Diabetic Retinopathy: Analysis From a Pivotal Multi-center Prospective Clinical Trial
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2019